0001832415-23-000004.txt : 20230811
0001832415-23-000004.hdr.sgml : 20230811
20230811160137
ACCESSION NUMBER: 0001832415-23-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
EFFECTIVENESS DATE: 20230811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Better Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832415
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-489531
FILM NUMBER: 231163888
BUSINESS ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
BUSINESS PHONE: 415-887-2311
MAIL ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II
DATE OF NAME CHANGE: 20201116
D
1
primary_doc.xml
X0708
D
LIVE
0001832415
Better Therapeutics, Inc.
548 MARKET ST. #49404
SAN FRANCISCO
CA
CALIFORNIA
94101
(415) 887-2311
DELAWARE
Mountain Crest Acquisition Corp II
Corporation
true
2020
Frank
Karbe
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Executive Officer
Director
David
Perry
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Executive Officer
Director
Mark
Berman
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Executive Officer
Kristin
Wynholds
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Executive Officer
Mark
Heinen
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Executive Officer
Richard
Carmona
c/o Better Therapeutics, Inc.
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Director
Andrew
Armanino
c/o Better Therapeutics, Inc.
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Director
Risa
Lavizzo-Mourey
c/o Better Therapeutics, Inc.
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Director
Geoffrey
Parker
c/o Better Therapeutics, Inc.
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Director
Elder
Granger
c/o Better Therapeutics, Inc.
548 Market St. #49404
San Francisco
CA
CALIFORNIA
94104
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-07-27
false
true
false
0
Chardan Capital Markets LLC
120128
None
None
17 State Street, Suite 2130
New York
NY
NEW YORK
10004
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
IL
ILLINOIS
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
WA
WASHINGTON
true
Titan Partners Group LLC, a division of American Capital Partners, LLC
44656
None
None
7 World Trade Center, 46th Floor
New York
NY
NEW YORK
10007
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
IL
ILLINOIS
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
WA
WASHINGTON
true
2114998
2114998
0
Private placement of 2,897,654 shares of common stock at a price of $0.7299 per share.
false
10
126900
0
0
false
Better Therapeutics, Inc.
/s/ Mark Heinen
Mark Heinen
Chief Financial Officer
2023-08-11